Showing results (1-10 of 302) with videos related to
Sort By:
Pageof 31
Digestive Diseases (Basel, Switzerland)|June 22, 2011
Ursodeoxycholic acid for treatment of fatty liver disease and dyslipidemia in morbidly obese patientsHanns-Ulrich Marschall, Martin Wagner, Gernot Zollner, et al.Expert Review of Gastroenterology & Hepatology|August 28, 2015
Management of intrahepatic cholestasis of pregnancyHanns-Ulrich MarschallJournal of Hepatology|May 24, 2003
Adaptive changes in hepatobiliary transporter expression in primary biliary cirrhosisGernot Zollner, Peter Fickert, Dagmar Silbert, et al.Journal of Hepatology|February 16, 2005
Oncosis represents the main type of cell death in mouse models of cholestasisPeter Fickert, Michael Trauner, Andrea Fuchsbichler, et al.Digestion|September 12, 2012
Combined rifampicin and ursodeoxycholic acid treatment does not amplify rifampicin effects on hepatic detoxification and transport systems in humansHanns-Ulrich Marschall, Martin Wagner, Gernot Zollner, et al.Current Hepatology Reports|July 15, 2017
Why Doesn't Primary Biliary Cholangitis Respond to Immunosuppressive Medications?Antonio Molinaro, Hanns-Ulrich MarschallLakartidningen|March 16, 2016
[Bleeding and thrombosis – acute complications of liver cirrhosis]Rupesh Rajani, Hanns-Ulrich MarschallBiochemical Society Transactions|February 22, 2022
Bile acid metabolism and FXR-mediated effects in human cholestatic liver disordersAntonio Molinaro, Hanns-Ulrich MarschallHepatology (Baltimore, Md.)|June 30, 2005
CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in miceMartin Wagner, Emina Halilbasic, Hanns-Ulrich Marschall, et al.Acta Obstetricia Et Gynecologica Scandinavica|October 20, 2010
Decreased 1,25-dihydroxy vitamin D levels in women with intrahepatic cholestasis of pregnancyElisabeth Wikström Shemer, Hanns-Ulrich MarschallPageof 31